| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 15 | 2025 | 1406 | 3.150 |
Why?
|
| Glioblastoma | 11 | 2024 | 372 | 3.090 |
Why?
|
| Neoplastic Stem Cells | 10 | 2024 | 352 | 2.710 |
Why?
|
| Chromatin | 6 | 2023 | 617 | 1.830 |
Why?
|
| Glioma | 3 | 2025 | 535 | 1.740 |
Why?
|
| Caenorhabditis elegans | 6 | 2011 | 244 | 1.230 |
Why?
|
| Medulloblastoma | 5 | 2025 | 571 | 1.210 |
Why?
|
| Caenorhabditis elegans Proteins | 6 | 2011 | 97 | 1.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2025 | 2137 | 0.990 |
Why?
|
| Polyamines | 1 | 2025 | 31 | 0.970 |
Why?
|
| Synapses | 1 | 2025 | 470 | 0.740 |
Why?
|
| Histones | 4 | 2025 | 572 | 0.730 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2022 | 236 | 0.690 |
Why?
|
| Butyrophilins | 1 | 2020 | 1 | 0.680 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 50 | 0.660 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2020 | 83 | 0.650 |
Why?
|
| Longevity | 3 | 2011 | 159 | 0.630 |
Why?
|
| Genes, Homeobox | 2 | 2023 | 72 | 0.600 |
Why?
|
| Cerebellar Neoplasms | 4 | 2025 | 461 | 0.590 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2016 | 124 | 0.580 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 719 | 0.560 |
Why?
|
| Carcinogenesis | 1 | 2020 | 363 | 0.550 |
Why?
|
| Mutation | 9 | 2025 | 6350 | 0.510 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1125 | 0.510 |
Why?
|
| Ependymoma | 3 | 2025 | 176 | 0.500 |
Why?
|
| Epigenesis, Genetic | 6 | 2024 | 771 | 0.480 |
Why?
|
| Neurons | 1 | 2025 | 2051 | 0.470 |
Why?
|
| Genes, Helminth | 3 | 2011 | 22 | 0.470 |
Why?
|
| Cancer Care Facilities | 1 | 2025 | 40 | 0.470 |
Why?
|
| Gene Expression Profiling | 7 | 2022 | 1922 | 0.460 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 820 | 0.450 |
Why?
|
| DNA Methylation | 6 | 2024 | 1148 | 0.440 |
Why?
|
| Anion Transport Proteins | 2 | 2011 | 31 | 0.440 |
Why?
|
| Cell Differentiation | 5 | 2024 | 2044 | 0.430 |
Why?
|
| Medical Oncology | 1 | 2025 | 247 | 0.410 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 1316 | 0.400 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1721 | 0.390 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 75 | 0.380 |
Why?
|
| Precision Medicine | 1 | 2025 | 361 | 0.370 |
Why?
|
| Cell Proliferation | 7 | 2025 | 2562 | 0.360 |
Why?
|
| Genes, Mitochondrial | 1 | 2011 | 21 | 0.360 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 3800 | 0.350 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2024 | 323 | 0.330 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2024 | 63 | 0.330 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 188 | 0.320 |
Why?
|
| Animals | 19 | 2025 | 36521 | 0.310 |
Why?
|
| Humans | 28 | 2025 | 134196 | 0.310 |
Why?
|
| Pheromones | 1 | 2009 | 16 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3509 | 0.300 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 297 | 0.300 |
Why?
|
| Mitochondria | 2 | 2011 | 758 | 0.300 |
Why?
|
| Energy Metabolism | 2 | 2011 | 814 | 0.290 |
Why?
|
| Whole Genome Sequencing | 2 | 2020 | 325 | 0.280 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 2178 | 0.280 |
Why?
|
| Mice, SCID | 4 | 2025 | 615 | 0.280 |
Why?
|
| Genome, Human | 3 | 2024 | 1350 | 0.270 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 1109 | 0.260 |
Why?
|
| Neoplasms | 3 | 2025 | 3035 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 1013 | 0.260 |
Why?
|
| Mice | 11 | 2025 | 19045 | 0.260 |
Why?
|
| Fatty Acids | 1 | 2009 | 372 | 0.250 |
Why?
|
| Insulin | 1 | 2011 | 1260 | 0.240 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 700 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2025 | 4936 | 0.240 |
Why?
|
| Meninges | 1 | 2025 | 22 | 0.240 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 318 | 0.230 |
Why?
|
| Genomics | 3 | 2024 | 1678 | 0.230 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2025 | 21 | 0.230 |
Why?
|
| Child | 7 | 2025 | 25917 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1144 | 0.230 |
Why?
|
| Epigenomics | 3 | 2024 | 196 | 0.230 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 407 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 1434 | 0.220 |
Why?
|
| Apoptosis | 1 | 2011 | 1945 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2025 | 2735 | 0.200 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2023 | 82 | 0.200 |
Why?
|
| Genetic Heterogeneity | 2 | 2024 | 143 | 0.200 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 217 | 0.200 |
Why?
|
| Prognosis | 4 | 2023 | 5084 | 0.190 |
Why?
|
| Astrocytoma | 1 | 2022 | 112 | 0.180 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 248 | 0.180 |
Why?
|
| Genomic Structural Variation | 1 | 2022 | 92 | 0.170 |
Why?
|
| Lactobacillus johnsonii | 1 | 2020 | 2 | 0.170 |
Why?
|
| Inosine | 1 | 2020 | 12 | 0.170 |
Why?
|
| Larva | 3 | 2011 | 262 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 150 | 0.170 |
Why?
|
| Intestinal Neoplasms | 1 | 2020 | 41 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 793 | 0.160 |
Why?
|
| Bifidobacterium | 1 | 2020 | 70 | 0.160 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 363 | 0.160 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 108 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 390 | 0.160 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 255 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 324 | 0.160 |
Why?
|
| B7 Antigens | 1 | 2019 | 14 | 0.160 |
Why?
|
| Disease | 1 | 2020 | 133 | 0.160 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 110 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 720 | 0.150 |
Why?
|
| Models, Biological | 1 | 2024 | 1538 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2017 | 371 | 0.140 |
Why?
|
| Female | 10 | 2025 | 72037 | 0.140 |
Why?
|
| Drosophila | 1 | 2022 | 829 | 0.140 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 972 | 0.140 |
Why?
|
| Telomerase | 1 | 2018 | 179 | 0.140 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 370 | 0.140 |
Why?
|
| Cell Tracking | 1 | 2017 | 17 | 0.140 |
Why?
|
| Transcriptome | 1 | 2024 | 1135 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 260 | 0.140 |
Why?
|
| Genome | 1 | 2020 | 529 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2020 | 507 | 0.140 |
Why?
|
| CpG Islands | 2 | 2018 | 347 | 0.130 |
Why?
|
| Drosophila Proteins | 1 | 2022 | 773 | 0.130 |
Why?
|
| Male | 7 | 2025 | 66197 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2010 | 1051 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 562 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2011 | 874 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2020 | 750 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1512 | 0.110 |
Why?
|
| Drug Design | 1 | 2015 | 168 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 1036 | 0.110 |
Why?
|
| Canada | 1 | 2025 | 346 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 65 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 548 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1762 | 0.110 |
Why?
|
| Transfection | 1 | 2015 | 1098 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 97 | 0.100 |
Why?
|
| Melanoma | 1 | 2020 | 969 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 268 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2025 | 199 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 907 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1880 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 823 | 0.100 |
Why?
|
| Phenotype | 4 | 2021 | 4610 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 249 | 0.090 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 160 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 176 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2011 | 32 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 139 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 100 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2949 | 0.090 |
Why?
|
| Aging | 2 | 2010 | 1308 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1783 | 0.080 |
Why?
|
| Pediatrics | 1 | 2020 | 1221 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 546 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2012 | 1138 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 399 | 0.080 |
Why?
|
| Germ Cells | 1 | 2011 | 204 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2010 | 60 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 403 | 0.080 |
Why?
|
| Adult | 3 | 2022 | 31948 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1070 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 327 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 356 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1764 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 1854 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 532 | 0.070 |
Why?
|
| Time Factors | 2 | 2015 | 6595 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 805 | 0.070 |
Why?
|
| Models, Animal | 1 | 2010 | 485 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 389 | 0.070 |
Why?
|
| Protein Binding | 1 | 2011 | 1860 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 949 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 488 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 3978 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1621 | 0.060 |
Why?
|
| Cell Line | 1 | 2011 | 2863 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2025 | 32 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2025 | 45 | 0.060 |
Why?
|
| Embryonic Structures | 1 | 2025 | 9 | 0.060 |
Why?
|
| Metencephalon | 1 | 2025 | 11 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 673 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 344 | 0.060 |
Why?
|
| Infratentorial Neoplasms | 1 | 2024 | 48 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 162 | 0.050 |
Why?
|
| Biglycan | 1 | 2023 | 7 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2023 | 25 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2015 | 14897 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2793 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 9961 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 59 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 222 | 0.040 |
Why?
|
| Hypoxia | 1 | 2022 | 268 | 0.040 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2020 | 11 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2020 | 68 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 223 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 129 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 589 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 580 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 375 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 1622 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 320 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2017 | 38 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 20646 | 0.030 |
Why?
|
| Clone Cells | 1 | 2017 | 180 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 201 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 399 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 677 | 0.030 |
Why?
|
| Plicamycin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2014 | 37 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2014 | 34 | 0.030 |
Why?
|
| Infant | 2 | 2024 | 13262 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 57 | 0.030 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2014 | 29 | 0.030 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2014 | 50 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2014 | 116 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2013 | 61 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 247 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 178 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 259 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 433 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2014 | 223 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 497 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 315 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1772 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3226 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4882 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1735 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 830 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2538 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1167 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1351 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2006 | 10 | 0.020 |
Why?
|
| Binding Sites | 1 | 2006 | 1386 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 790 | 0.010 |
Why?
|